Henrik Renlund

2.0k total citations
51 papers, 1.0k citations indexed

About

Henrik Renlund is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Henrik Renlund has authored 51 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Cardiology and Cardiovascular Medicine, 14 papers in Internal Medicine and 11 papers in Surgery. Recurrent topics in Henrik Renlund's work include Atrial Fibrillation Management and Outcomes (30 papers), Cardiac Arrhythmias and Treatments (16 papers) and Acute Myocardial Infarction Research (15 papers). Henrik Renlund is often cited by papers focused on Atrial Fibrillation Management and Outcomes (30 papers), Cardiac Arrhythmias and Treatments (16 papers) and Acute Myocardial Infarction Research (15 papers). Henrik Renlund collaborates with scholars based in Sweden, United Kingdom and United States. Henrik Renlund's co-authors include Anders Själander, Peter J Svensson, Stefan James, Gregory Y.H. Lip, Tomas Jernberg, Bo Lagerqvist, Christoph Varenhorst, Anders Sahlén, Lars Wallentin and Per Wester and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Henrik Renlund

47 papers receiving 1.0k citations

Peers

Henrik Renlund
Basil S. Lewis Israel
Kang-Ling Wang Taiwan
Mikhail Ruda United States
Simona Skerjanec United States
Thure Filskov Overvad Denmark
Ying X. Gue United Kingdom
Geneviève Salette France
J. Ycas United States
Petr Widimský Czechia
Helen Varker United States
Basil S. Lewis Israel
Henrik Renlund
Citations per year, relative to Henrik Renlund Henrik Renlund (= 1×) peers Basil S. Lewis

Countries citing papers authored by Henrik Renlund

Since Specialization
Citations

This map shows the geographic impact of Henrik Renlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Renlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Renlund more than expected).

Fields of papers citing papers by Henrik Renlund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Renlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Renlund. The network helps show where Henrik Renlund may publish in the future.

Co-authorship network of co-authors of Henrik Renlund

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Renlund. A scholar is included among the top collaborators of Henrik Renlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Renlund. Henrik Renlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Renlund, Henrik, et al.. (2025). Clinical outcomes of direct oral anticoagulant off-label dosing in nonvalvular atrial fibrillation. DiVA at Umeå University (Umeå University). 20. 100210–100210.
4.
Renlund, Henrik, et al.. (2024). Risk factors for major bleeding in patients with atrial fibrillation and CKD G3–G5D on oral anticoagulants. Clinical Kidney Journal. 17(8). sfae206–sfae206. 1 indexed citations
5.
James, Stefan, David Erlinge, Sasha Koul, et al.. (2024). Outcome of Saphenous Vein Graft Percutaneous Coronary Intervention Using Contemporary Drug-Eluting Stents: A SCAAR Report. SHILAP Revista de lepidopterología. 3(10). 102232–102232.
6.
Renlund, Henrik, et al.. (2024). Thromboembolic events, major bleeding and mortality in essential thrombocythaemia and polycythaemia vera—A matched nationwide population‐based study. British Journal of Haematology. 204(5). 1740–1751. 2 indexed citations
7.
8.
Renlund, Henrik, et al.. (2023). Warfarin treatment quality and outcomes in patients with non-valvular atrial fibrillation and CKD G3-G5D. Thrombosis Research. 229. 131–138. 2 indexed citations
9.
Schubert, Jessica, Bertil Lindahl, Håkan Melhus, et al.. (2020). Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study. European Heart Journal. 42(3). 243–252. 109 indexed citations
10.
Edfors, Robert, Anders Sahlén, Karolina Szummer, et al.. (2018). Outcomes in patients treated with ticagrelor versus clopidogrel after acute myocardial infarction stratified by renal function. Heart. 104(19). 1575–1582. 27 indexed citations
11.
Enblad, Gunilla, et al.. (2017). Risk Factors for De Novo Squamous Cell Carcinoma Development in Renal Transplant Recipients with a Previous Squamous Cell Carcinoma. Acta Dermato Venereologica. 97(6). 751–753. 1 indexed citations
12.
Norrving, Bo, et al.. (2016). Abstract 18795: Non-Vitamin K Oral Anticoagulants Are Non-Inferior for Stroke Prevention but Cause Fewer Major Bleedings Than Well-Managed Warfarin With Time in Therapeutic Range 70% or Higher in Sweden. Circulation. 1 indexed citations
13.
14.
Sahlén, Anders, Christoph Varenhorst, Bo Lagerqvist, et al.. (2016). Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry. European Heart Journal. 37(44). 3335–3342. 110 indexed citations
15.
Johnston, Nina, Christina Christersson, Tanja Kero, et al.. (2015). Effect of Gender on Patients With ST-Elevation and Non-ST-Elevation Myocardial Infarction Without Obstructive Coronary Artery Disease. The American Journal of Cardiology. 115(12). 1661–1666. 47 indexed citations
16.
Renlund, Henrik, et al.. (2015). Warfarin treatment complications do not correlate to cTTR when above 70%. Thrombosis Research. 136(6). 1185–1189. 7 indexed citations
17.
Renlund, Henrik, et al.. (2015). Safety and efficacy of well managed warfarin. Thrombosis and Haemostasis. 113(6). 1370–1377. 96 indexed citations
18.
Sahlén, Anders, Christoph Varenhorst, Bo Lagerqvist, et al.. (2015). Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). European Heart Journal - Cardiovascular Pharmacotherapy. 2(1). 5–12. 32 indexed citations
19.
Renlund, Henrik, et al.. (2015). Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden. Thrombosis Research. 136(2). 216–220. 23 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Basil S. Lewis Breakdown of academic impact, for papers by Kang-Ling Wang Breakdown of academic impact, for papers by Mikhail Ruda Breakdown of academic impact, for papers by Simona Skerjanec Breakdown of academic impact, for papers by Thure Filskov Overvad Breakdown of academic impact, for papers by Ying X. Gue Breakdown of academic impact, for papers by Geneviève Salette Breakdown of academic impact, for papers by J. Ycas Breakdown of academic impact, for papers by Petr Widimský Breakdown of academic impact, for papers by Helen Varker
Rankless by CCL
2026